Assessment of polypharmacy among aged people living with HIV and its impact on quality of life and adherence to anti-retroviral therapy
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Proportion of polypharmacy among aged PLHIV.
研究概览
简要总结
Polypharmacy is a growing concern among older PLHIV, because of adverse drug reactions, drug-drug interactions, reduced adherence to ART. Polypharmacy has been commonly reported in PLHIV and its prevalence varies from 15% to 55% in different studies. Polypharmacy can lead to harmful drug-drug interactions and have a significant impact on adherence to ART. Polypharmacy can lead to poor health outcomes, and worse quality of life in older PLHIV. There are limited systematic studies on the prevalence of polypharmacy among PLHIV from India and this study will assess the prevalence of polypharmacy among aged PLHIV and their impact on quality of life and ART adherence.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 50.00 Year(s) 至 99.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Confirmed HIV infection (as per NACO guidelines).
- •2.Age 50 years or more (UNAIDS definition of aged PLHIV).
- •3.Subjects on ART for atleast 1 year.
排除标准
- •Subjects with any serious medical condition, like neurological disease that prevents the Subjects answering the questionnaires.
结局指标
主要结局
Proportion of polypharmacy among aged PLHIV.
时间窗: Baseline
次要结局
- 1.Potential drug-drug interactions due to polypharmacy.(2.Effect of polypharmacy on the quality of life and anti-retroviral treatment adherence.)
研究者
RASHMI MEENA
Maulana Azad Medical College